These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 18799315)

  • 1. Deuterium isotope effects for the oxidation of 1-methyl-3-phenyl-3-pyrrolinyl analogues by monoamine oxidase B.
    Pretorius A; Ogunrombi MO; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2008 Oct; 16(19):8813-7. PubMed ID: 18799315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
    Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
    Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of 1-methyl-3-phenylpyrrolidine and 3-methyl-1-phenyl-3-azabicyclo[3.1.0]hexane with monoamine oxidase B.
    Pretorius A; Ogunrombi MO; Fourie H; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2010 Jun; 18(11):4111-8. PubMed ID: 20451395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of structural requirements for the monoamine oxidase-B-catalyzed oxidation of 1,4-disubstituted-1,2,3,6-tetrahydropyridine derivatives related to the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Mabic S; Castagnoli N
    J Med Chem; 1996 Sep; 39(19):3694-700. PubMed ID: 8809158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tert-butoxyl radical mediated hydrogen atom transfer reactions of the Parkinsonian proneurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and selected tertiary amines.
    Suleman NK; Flores J; Tanko JM; Isin EM; Castagnoli N
    Bioorg Med Chem; 2008 Sep; 16(18):8557-62. PubMed ID: 18713667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deuterium isotope effect studies on the MAO-B catalyzed oxidation of 4-benzyl-1-cyclopropyl-1,2,3,6-tetrahydropyridine.
    Anderson AH; Kuttab S; Castagnoli N
    Biochemistry; 1996 Mar; 35(10):3335-40. PubMed ID: 8605171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in the inhibition of monoamine oxidase B by 1-methyl-3-phenylpyrroles.
    Ogunrombi MO; Malan SF; Terre'blanche G; Castagnoli N; Bergh JJ; Petzer JP
    Bioorg Med Chem; 2008 Mar; 16(5):2463-72. PubMed ID: 18065227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deuterium isotope effect measurements on the interactions of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine with monoamine oxidase B.
    Ottoboni S; Caldera P; Trevor A; Castagnoli N
    J Biol Chem; 1989 Aug; 264(23):13684-8. PubMed ID: 2788162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroindazole compounds inhibit the oxidative activation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxin to neurotoxic pyridinium cations by human monoamine oxidase (MAO).
    Herraiz T; Arán VJ; Guillén H
    Free Radic Res; 2009 Oct; 43(10):975-84. PubMed ID: 19669997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative aromatic hydroxylation and N-demethylation of MPTP neurotoxin and its analogs, N-methylated beta-carboline and isoquinoline alkaloids, by human cytochrome P450 2D6.
    Herraiz T; Guillén H; Arán VJ; Idle JR; Gonzalez FJ
    Toxicol Appl Pharmacol; 2006 Nov; 216(3):387-98. PubMed ID: 16870220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity study of the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity. I. Evaluation of the biological activity of MPTP analogs.
    Youngster SK; Sonsalla PK; Sieber BA; Heikkila RE
    J Pharmacol Exp Ther; 1989 Jun; 249(3):820-8. PubMed ID: 2786564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the monoamine oxidase-B-catalyzed biotransformation of 4-azaaryl-1-methyl-1,2,3,6-tetrahydropyridine derivatives.
    Nimkar SK; Mabic S; Anderson AH; Palmer SL; Graham TH; de Jonge M; Hazelwood L; Hislop SJ; Castagnoli N
    J Med Chem; 1999 May; 42(10):1828-35. PubMed ID: 10346935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The behaviour of aryl pyrrolines with monoamine oxidase.
    Williams CH; Lawson J
    Neurobiology (Bp); 1999; 7(2):225-33. PubMed ID: 10591055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and monoamine oxidase B catalyzed oxidation of C-4 heteroaromatic substituted 1,2,3,6-tetrahydropyridine derivatives.
    Nimkar SK; Anderson AH; Rimoldi JM; Stanton M; Castagnoli KP; Mabic S; Wang YX; Castagnoli N
    Chem Res Toxicol; 1996 Sep; 9(6):1013-22. PubMed ID: 8870990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the mechanism of MPTP oxidation by human liver monoamine oxidase B.
    Gessner W; Brossi A; Bembenek ME; Fritz RR; Abell CW
    FEBS Lett; 1986 Apr; 199(1):100-2. PubMed ID: 3485542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of heart norepinephrine in mice by some analogs of MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine).
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1987 May; 56(2):147-56. PubMed ID: 3496637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the bioactivation of the neurotoxin MPTP by antioxidants, redox agents and monoamine oxidase inhibitors.
    Herraiz T; Guillén H
    Food Chem Toxicol; 2011 Aug; 49(8):1773-81. PubMed ID: 21554916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Catalytic biotransformation of physiologically active 1-methyl-4- aryl-1,2,3,6-tetrahydropyridines under the action of monoaminooxidase].
    Bachurin SO; Sablin SO; Grishina GV; Gaĭdarova EL; Dubova DG
    Bioorg Khim; 1989 May; 15(5):620-6. PubMed ID: 2788421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI; Riachi NJ; Hritz MA; Berridge MS; Sayre LM
    J Pharmacol Exp Ther; 1993 Aug; 266(2):790-5. PubMed ID: 8355208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.